ISCT Paris April 25. Ex vivo platelet production Dominique Baruch INSERM UMR-S1140, Paris

Similar documents
Physiology Unit 3 HEMATOLOGY

POST-ISTH: Novità dal meeting di Toronto 2015 Piastrine: fisiopatologia. Erica De Candia Università Cattolica -Roma

Membrane microvesicles: a circulating source for fibrinolysis, new antithrombotic

Interaction of blood cells with the vessel wall in thrombosis

LABORATORY APPROACH TO BLEEDING DISORDERS DR NISHANTH PG 1 ST YEAR DEPARTMENT OF PATHOLOGY

De l'utilisation de la microscopie intravitale pour étudier la thrombose in vivo et tester de nouveaux médicaments antithrombotiques- 1er partie

Hemostasis and Thrombosis

Hematology Emergencies: Problems with Platelets

Challenges in manufacture of human platelets for transfusion

Chapter 19b Blood, cont d

Department of Research Evaluation. Biology and pharmacology of blood platelets: haemostasis, thrombosis, transfusion

von Willebrand factor: a hemostatic protein

Supplementary Figure 1 Pfn1, but not other Pfn isoforms are expressed in

At the conclusion of this lesson you should be able to:

(B) Comparable expression of major integrin subunits and glycoproteins on the surface of resting WT and Lnk -/- platelets.

Hemostasis. by Mohie-Aldien Elsayed

engineering microvasculature-on-chip models as research-enabling systems for hemostasis and thrombosis

The Cardiovascular System: Blood

The Coagulation Workup In The Office Setting

Sign up to receive ATOTW weekly -

Ch 13: Blood. What does blood do? Transport: Regulation: Protection:

Local vasoconstriction. is due to local spasm of the smooth muscle (symp. reflex) can be maintained by platelet vasoconstrictors

International Society Laboratory Hematology Milan, May Current and Emerging Approaches for Assessing von Willebrand disease (VWD) in 2016

NEXT GENERATION ECM-BASED ALLOGRAFT TECHNOLOGY:

Farnesoid X Receptor and its ligands inhibit the function of platelets

Platelet Adhesion and Aggregation Assays

OVERVIEW OF LABORATORY DIAGNOSTIC TESTING FOR PLATELET DISORDERS

Alternativmethodezumknock-out Modell in der Arterioskleroseforschung: Sascha Meyer dos Santos

Common Inherited Bleeding Disorders

Activation and specificity of Thrombin. Giulia Pavani

Overview of Anatomy and Physioloy II Second Year Students

Profibrinolytic diabody targeting PAI-1 and TAFI for treatment of acute thrombotic disorders

UvA-DARE (Digital Academic Repository) Factor XI as target for antithrombotic therapy van Montfoort, M.L. Link to publication

Disclaimer: this is a very big topic and coverage will be only superficial.

THE SCIENCE OF PLATELET RICH PLASMA

Regulation of Hematopoietic Stem Cells and their Bone Marrow Niches by the Coagulation System*.

Platelet Refractoriness: The Basics. Martin H. Bluth, MD, PhD

BLOOD COAGULATION. 1. The initial phase of the process is vascular constriction. This limits the flow of blood to the area of injury.

Platelet deposition (%) Fibronectin

Chapter 8 Healthcare Biotechnology

بسم اهلل الرمحن الرحيم

Coagulopathy Case-2. Andy Nguyen, M.D. 2009

SUPPLEMENTAL MATERIAL. Supplemental Methods:

Adult Stem Cells for Chronic Pain. Dr. John Hughes, DO January 24 th, 2018

General Principles of. Hemostasis. Kristine Krafts, M.D.

SmartPReP 2: The Gold Standard

Discover TruPRP. PRP the way you want it.

Supplement Figure 1. Characterization of the moab. (A) A series of moabs that are anti-hαiib-specific were tested for their ability to bind to

Syringe Pumps. Please contact us for help in selecting the best pump for your application and a free quote.

Session 1 Topics. Vascular Phase of Hemostasis. Coagulation Pathway. Action of Unfractionated Heparin. Laboratory Monitoring of Anticoagulant Therapy

These handouts are only meant as a guide while you follow the presentation on the screen. Sometimes the speaker will change some of the slides.

PROVINCIAL BLOOD COORDINATING PROGRAM DEFINITIONS NLBCP-063

Coagulation Mechanisms Dr. Nervana Bayoumy

Common Inherited Coagulation Disorders. Inherited Coagulation Disorders. All coagulation factors and platelets in circulation (unactivated)

Plasma fibronectin supports hemostasis and regulates thrombosis

Case 1. Case 1. Case 2. Case 2. Review of Bleeding Disorders Case 1

Platelets in mammals are anucleated cells that originate. Reviews. Adhesion Mechanisms in Platelet Function

Regulation of advanced blood cell therapies

Stem Cell Research From Bench to Bedside

Person responsible (Chair): Martine Jandrot-Perrus, Hans Deckmyn

Introduction Hemostasis: Tourniquet Test & Bleeding Time. Hematology-Immunology System Faculty of Medicine Universitas Padjadjaran LOGO

Understanding Megakaryopoiesis And Thrombopoiesis Using Human Stem Cells Models

HIGH-THROUGHPUT HUMAN TISSUE AND DISEASE MODELS. Organ on a chip. Now.

KILLING THROMBUS WITH

Dr. Susan Louw Haematopathologist NHLS / WITS / SASTH

Personal history of excessive mucocutaneous bleeding. Family history of excessive bleeding. Laboratory tests of hemostasis consistent with VWD

Clinical Policy: Humate-P (Antihemophiliac Factor/von Willebrand Factor Complex Human) Reference Number: CP.MP.404

Generation of HLA universal platelets for regenerative applications

SUPPLEMENTAL FIGURES/TABLES:

Factor Concentrates. More is better? Alexander Duncan MD Emory Medical Labs

What Can We Learn from Animal Models of Coagulopathy and Bleeding (about plasma transfusion)?

Scientific Workshop. Melbourne Convention and Exhibition Centre Level 2, Meeting Rooms 218 and 219 Melbourne

A revised model of platelet aggregation

Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration. JournalClub Emilie Hrdliczka

Supplementary Figure 1 Caspase-8 deficient platelets respond normally to agonists and ABT-737 (A) Surface expression of GPIX, GPIb, GPVI and CD41

BUILT TO CONCENTRATE. Magellan is an autologous concentration system that delivers concentrated platelets and cells at the point of care.

Cardiovascular (connective tissue)

-- Laki J. Rousou, MS, MD et. al. -- Boston, Massachusetts. -- Ann Thorac Surg 2009;87:62 70.

SMART HEALTH PROJECT

Present and future of regenerative medicine. Liver Transplantation

The Power in You. TM

LABORATORY APPROCH TO THE BLEEDING PATIENT

Developing Targeted Stem Cell Therapeutics for Cancer. Shawn Hingtgen, Ph.D. Assistant Professor UNC Eshelman School of Pharmacy May 22 nd, 2013

VIII. Validation Evaluation Comparative Chart Application Fields of PRP Advantages of MiroPRP for skin treatments MicroPRP and Mico-Mesotherapy

Platelet type bleeding: (vwd) - Petechiae, purpura, ecchymoses, bruising - Menorrhagia, hematuria, occult GI bleed - Gingival bleeding, epistaxis

Alberta Health Services - Edmonton Zone Massive Hemorrhage Protocol

Adv Pathophysiology Unit 4 Page 1 of 10. Learning Objectives for this file:

ANAT 3231 Cell Biology Lecture 21 Stem Cells

Bivalirudin (Angiomax ) vs. Heparin during Peripheral Vascular Interventions: Which is Better and How to Decide?

SUPPLEMENTAL MATERIAL. von Willebrand Factor unfolding and elongation on collagen during acute whole blood exposure to pathological flow

Isolation of mouse monocytes: Mouse monocytes were isolated using a modified

Microparticles in platelet concentrates are a key indicator of the level of platelet activation. This is a topic that is critically important to

ANAT 2341 Embryology Lecture 18 Stem Cells

10/17/ /17/2017

UNCLASSIFIED AD DEFENSE DOCUMENTATION CENTER FOR SCIENTIFIC AND TECHNICAL INFORMATION CAMERON STATION, ALEXANDRIA. VIRGINIA UNCLASSIFIED

Cellular repair of damaged organs. Repopulating scaffoldings in kidney and liver

SUPPLEMENTARY FIGURE 1

STANDARD BLOOD PRODUCTS AND SERVICES

Dr Alain Gondinet of ReGen Lab reviews cell therapies using platelet rich plasma autologous cellular regeneration

Transcription:

ISCT Paris April 25 Ex vivo platelet production Dominique Baruch INSERM UMR-S1140, Paris

Platelet functions: to stop bleeding and beyond Adhesion Aggregation Clot retraction Secretion Procoagulant activity Microparticules «Additional platelet functions continue to come to light, and biologists have just described a novel way that the body might make these multitalented cells a finding that could one day ease the demand for donated blood.» Angiogenesis Source of growth factors Inflammation Immunity Sepsis Metastasis Post-natal vascular remodelling D.Baruch Platelet formation ISCT 25/04/2014 2

In vivo platelet production from megakaryocytes Science (2007) Migration of a mouse EYFP- IIb megakaryocyte near a sinusoid Passage of large MK fragments in the circulation 50 m Peripheral venous blood proplatelets D.Baruch Platelet formation ISCT 25/04/2014 3

Role of VWF and shear rates on platelet production To address the role of blood flow on megakaryocyte fragmentation into platelets using a VWF-coated surface Perfusion of human mature megakaryocytes in a parallel-plate flow chamber at high shear rates Videomicroscopy recording of single cell trajectories for 30 mins Human megakaryocytes 13 days culture D.Baruch Platelet formation ISCT 25/04/2014 4

Proplatelet and platelet formation from human megakaryocytes at high shear rates Flow D.Baruch Platelet formation ISCT 25/04/2014 5

Role of microtubules in proplatelet formation 10 images/s Flow D.Baruch Platelet formation ISCT 25/04/2014 6

Shear-derived platelets can be activated by thrombin No thrombin Thrombin D.Baruch Platelet formation ISCT 25/04/2014 7

Platelet production from mouse megakaryocytes Bioflux mvwf D.Baruch Platelet formation ISCT 25/04/2014 8

Shear-induced mouse platelets are functional in vivo in a thrombosis model Topical lesion by FeCl3 on mesenteric vessels Infusion of labelled platelets Intra-vital microscopy : real-time platelet thrombus formation Shear-derived platelets incorporate in thrombus of mesenteric vessels Static conditions or BSA do not support platelet thrombus formation D.Baruch Platelet formation ISCT 25/04/2014 9

Is platelet production regulated by Willebrand factor? Transition in circulating blood between different fragmentations states : from preplatelets to proplatelets and to platelets VWF? Adapted from Thon JN et al, JBC 2010 What would be the role of VWF in terminal platelet production? D.Baruch Platelet formation ISCT 25/04/2014 10

% proplatelets Terminal platelet production in Willebrand factor deficiency Role of exposure of platelets to VWF during their formation Experiments with human VWF deficient platelets of a patient with severe von Willebrand disease :absence of VWF in plasma, platelets, and endothelial cells A pre post C severe VWD 40 35 30 25 B pre post Control 20 15 10 5 0 0 4 6 8 12 16 20 24 28 Poirault-Chassac & al. PLOS One 2013 D.Baruch Platelet formation ISCT 25/04/2014 11

VWF Knock out mouse model proplatelet WT VWF -/- platelet WT KO VWF -/- Proplatelets D.Baruch Platelet formation ISCT 25/04/2014 12

Role of VWF in terminal platelet production VWF The role of VWF in terminal platelet production is: 1. To allow the conversion of preplatelets to proplatelets 2. To allow terminal fragmentation of proplatelets into platelets Proplatelets: reservoir of platelets ready to replace platelets needed to repair vessel injury Compatible model with small number of megakaryocytes leaving the bone marrow and the large daily circulating platelet production D.Baruch Platelet formation ISCT 25/04/2014 13

Megakaryocytic differentiation in 2D culture and 3D scaffolds D2 D12 D16 2D liquid culture Immature cells Mature MK D2 D6 D9 3D culture D12 D23 D30 Prolongation of cell survival and MK differentiation up to D30 in 3D scaffolds vs D16 in liquid culture D.Baruch Platelet formation ISCT 25/04/2014 14

Platelet production in 3D conditions 3D No activation Thrombin activation Liquid culture Increased platelet production in 3D conditions Platelets produced in flow conditions are functional D.Baruch Platelet formation ISCT 25/04/2014 15

Platelet production from induced pluripotent stem cells Takayama & al. J. Exp. Medicine 2010 The Nobel Prize in Physiology or Medicine 2012 D.Baruch Platelet formation ISCT 25/04/2014 16

Optimization of platelet production from induced pluripotent stem cells Eto & al. Cell Stem Cell 2014 D.Baruch Platelet formation ISCT 25/04/2014 17

Perspectives Innovative source of platelets for tomorrow s platelet transfusion? PLASMIS Large-scale platelet production from stem cells in microfluidic devices D.Baruch Platelet formation ISCT 25/04/2014 18

Acknowledgements INSERM UMR_S1140 and Paris Sorbonne University Claire Dunois-Lardé Sonia Poirault-Chassac Audrey Pietrzyk Alexandre Kauskot Kim-Anh Nguyen PLASTHER CONSORTIUM INSERM U1016 Isabelle Dusanter INSERM U770 Cécile Denis INSERM UMR_S1148 and Paris Sorbonne University Catherine Le Visage Didier Letourneur Mohamed Derkaoui PLASMIS CONSORTIUM UMR CNRS7083 INSERM U1009 Mathilde Reyssat Najet Debili INSERM U1016 INSERM U770 Isabelle Dusanter Cécile Denis Lab Hematology CHU Bichat Paris Nadine Ajzenberg Lab Hematology CHU HEGP Paris Pascale Gaussem Lab Thrombosis Research KU Leuven Hans Deckmyn D.Baruch Platelet formation ISCT 25/04/2014 19